Skip to content
value.today

Mnemosyne Pharmaceuticals Inc

Total raised
$12 M
1 round on record
Latest round
$12 M
Feb 2012
First round on record
Feb 2012
Today
Private
No later event on record

Funding rounds

1 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Mnemosyne Pharmaceuticals Inc
MonthRaisedRaiseSizeInvestorsSoldFiling
Feb 2012$12 MNo. 1$10 to $50 million

Mnemosyne Pharmaceuticals Inc: Raise no. 1, Feb 2012

Investors in this round

6 investors had bought by the notice of Feb 4, 2015: 6 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$12 M of $13 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Frank Menniti · Executive Officer
  • Vanessa King · Executive Officer, Director
  • James Bristol · Director
  • Peter Barrett · Director
  • Richard Horan · Director
  • William Koster · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Series A Convertible Preferred Stock”

Signed by Vanessa King, Ceo. Source: SEC Form D and 3 amendments, newest notice filed Feb 4, 2015. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Mnemosyne Pharmaceuticals Inc chose not to state its revenue in its newest notice of a funding round (Feb 2015).

    SEC Form D · Feb 2015

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Feb 2015

That is all the official record says: Mnemosyne Pharmaceuticals Inc has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Mnemosyne Pharmaceuticals Inc is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 1 round above had up to 6 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Mnemosyne Pharmaceuticals Inc
NameRoleNamed in
Frank MennitiExecutive officerFeb 2015
Vanessa KingExecutive officerFeb 2015
Kollol PalExecutive officerJul 2013
James BristolDirectorFeb 2015
Peter BarrettDirectorFeb 2015
Richard HoranDirectorFeb 2015
Vanessa KingDirectorFeb 2015
William KosterDirectorFeb 2015
Kollol PalDirectorJul 2013
Jared FertmanDirectorFeb 2013
Jessica BarnesDirectorFeb 2013
Benjamin BronsteinDirectorFeb 2012
Daniel BehrDirectorFeb 2012